BDMDW Baird Medical Investment Holdings Limited

Fundamentals / CIK 0001982444 / USD
Other share classes on CIK 0001982444: BDMD

Baird Medical Investment Holdings Limited reported $22.54M in revenue and a net loss of $27.28M for the fiscal year ended December 31, 2025 (down 39.2% year over year), with a 83.8% gross margin and a -113.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BDMDW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$39.38M$19.69M$0-$28.65MFY 2022 Revenue: $35.09MFY 2022 Net Income: $12.57M2022FY 2023 Revenue: $31.46MFY 2023 Net Income: $10.55M2023FY 2024 Revenue: $37.04MFY 2024 Net Income: $12.45M2024FY 2025 Revenue: $22.54MFY 2025 Net Income: -$27.28M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $22.54M $37.04M $31.46M $35.09M
Cost of Revenue $3.65M $4.38M $4.23M $7.05M
Gross Profit $18.88M $32.65M $27.23M $28.04M
Research & Development $20.13M $6.17M $4.27M $3.86M
Selling, General & Admin $24.38M $11.16M $11.09M $10.55M
Total Operating Expenses $44.51M $17.34M $15.37M $14.41M
Operating Income -$25.63M $15.32M $11.86M $13.63M
EBITDA -$24.53M $16.45M $12.88M $14.55M
Interest Income -- $393 $1.6K $8.6K
Interest Expense $737K $576K $284K $299K
Income Before Tax -$26.37M $14.09M $12.36M $14.52M
Income Tax Expense $1.17M $1.49M $1.70M $1.75M
Net Income -$27.28M $12.45M $10.55M $12.57M
Basic EPS -$0.98 $0.57 $0.51 $0.49
Diluted EPS -$0.98 $0.57 $0.51 $0.49
Basic Shares Outstanding 27.8M 21.8M 20.6M 25.6M
Diluted Shares Outstanding 27.8M 21.8M 20.6M 25.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for BDMDW.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $178K $2.97M $1.51M
Cash & Short-Term Investments $178K $2.97M $1.51M
Accounts Receivable, Net $42.53M $46.58M $31.10M
Inventory $1.09M $1.30M $1.14M
Total Current Assets $54.97M $61.42M $40.08M
Property, Plant & Equipment, Net $6.37M $7.14M $6.14M
Goodwill $60K $58K $59K
Intangible Assets $8.6K $17K $25K
Total Non-Current Assets $14.73M $16.55M $16.63M
Total Assets $69.70M $77.96M $56.71M
Accounts Payable $1.81M $1.25M $550K
Short-Term Debt $2.64M $868K $817K
Deferred Revenue (Current) $793K $792K $500K
Other Current Liabilities $4.89M $3.70M $3.79M
Total Current Liabilities $32.36M $34.62M $18.98M
Long-Term Debt $6.09M $3.44M $1.61M
Total Non-Current Liabilities $6.11M $3.58M $2.03M
Total Liabilities $38.48M $38.20M $21.00M
Total Debt (incl. Leases) $8.87M $4.71M $3.33M
Common Stock $3.1K $2.6K $2.6K
Retained Earnings -$515K $26.76M $14.39M
Accumulated Other Comp. Income -$1.37M -$3.14M -$2.01M
Total Stockholders' Equity $31.37M $39.66M $35.75M
Total Equity $31.22M $39.76M $35.71M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31
Cash & Cash Equivalents $178K $2.97M $1.51M
Cash & Short-Term Investments $178K $2.97M $1.51M
Accounts Receivable, Net $42.53M $46.58M $31.10M
Inventory $1.09M $1.30M $1.14M
Total Current Assets $54.97M $61.42M $40.08M
Property, Plant & Equipment, Net $6.37M $7.14M $6.14M
Goodwill $60K $58K $59K
Intangible Assets $8.6K $17K $25K
Total Non-Current Assets $14.73M $16.55M $16.63M
Total Assets $69.70M $77.96M $56.71M
Accounts Payable $1.81M $1.25M $550K
Short-Term Debt $2.64M $868K $817K
Deferred Revenue (Current) $793K $792K $500K
Other Current Liabilities $4.89M $3.70M $3.79M
Total Current Liabilities $32.36M $34.62M $18.98M
Long-Term Debt $6.09M $3.44M $1.61M
Total Non-Current Liabilities $6.11M $3.58M $2.03M
Total Liabilities $38.48M $38.20M $21.00M
Total Debt (incl. Leases) $8.87M $4.71M $3.33M
Common Stock $3.1K $2.6K $2.6K
Retained Earnings -$515K $26.76M $14.39M
Accumulated Other Comp. Income -$1.37M -$3.14M -$2.01M
Total Stockholders' Equity $31.37M $39.66M $35.75M
Total Equity $31.22M $39.76M $35.71M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$27.54M $12.60M $10.66M $12.77M
Depreciation & Amortization $1.10M $1.14M $1.01M $916K
Stock-Based Compensation $17.47M $0 $0 --
Change in Receivables $5.35M -$17.80M -$9.67M -$14.84M
Change in Inventory $260K -$188K $114K $1.57M
Change in Payables $484K $728K $342K -$101K
Operating Cash Flow -$1.34M -$6.31M -$1.02M $486K
Capital Expenditure -$42K -$2.85M -$2.64M -$5.91M
Free Cash Flow -$1.39M -$9.17M -$3.66M -$5.42M
Investing Cash Flow -$42K -$2.47M -$2.65M -$5.92M
Financing Cash Flow -$1.39M $10.33M $3.48M $4.41M
Net Change in Cash -$2.40M $1.46M -$200K -$1.32M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for BDMDW.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 83.8% 88.2% 86.6% 79.9%
Operating Margin -113.7% 41.4% 37.7% 38.8%
Net Profit Margin -121.0% 33.6% 33.5% 35.8%
Return on Equity (ROE) -87.0% 31.4% 29.5% --
Return on Assets (ROA) -39.1% 16.0% 18.6% --
Current Ratio 1.70x 1.77x 2.11x --
Quick Ratio 1.66x 1.74x 2.05x --
Debt to Equity 0.28x 0.12x 0.09x --
Revenue Growth (YoY) -39.2% +17.7% -10.4% --
Gross Profit Growth (YoY) -42.2% +19.9% -2.9% --
Operating Income Growth (YoY) -267.4% +29.1% -13.0% --
Net Income Growth (YoY) -319.0% +18.1% -16.1% --
EPS Growth (YoY) -271.9% +11.8% +4.1% --
Operating Cash Flow Growth (YoY) -- -- -309.9% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for BDMDW.
Source: SEC EDGAR CompanyFacts (CIK 0001982444) · from December 31, 2022 Data through December 31, 2025 · synced Nov 21, 2026, 05:10 UTC · Open in terminal